Alliance Pharma (LON:APH) Reaches New 52-Week High – What’s Next?

Alliance Pharma plc (LON:APH)’s share price reached a new 52-week high during trading on Thursday . The company traded as high as GBX 61.60 ($0.76) and last traded at GBX 61.40 ($0.76), with a volume of 519622 shares traded. The stock had previously closed at GBX 61.20 ($0.76).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank cut Alliance Pharma to a “hold” rating and decreased their target price for the stock from GBX 7,000 ($86.84) to GBX 6,250 ($77.53) in a report on Wednesday, January 29th.

Alliance Pharma Stock Up 0.2 %

The firm’s 50-day moving average price is GBX 52.53 and its 200-day moving average price is GBX 45.36. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The company has a market cap of £332.45 million, a price-to-earnings ratio of -1,025.00, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.